• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定一种主要的血清DNA结合蛋白为替代补体途径的B因子。

Identification of a major serum DNA-binding protein as factor B of the alternative complement pathway.

作者信息

Gardner W D, Haselby J A, Hoch S O

出版信息

J Immunol. 1980 Jun;124(6):2800-6.

PMID:6989908
Abstract

One of the major proteins in human serum capable of binding DNA has been shown to be factor B of the alternative pathway of complement activation. This protein, designated DNA-binding protein-2 (DBP-2), is recognized by antisera directed against both factor B and its activated form, fragment Bb. Its m.w., charge microheterogeneity, and amino acid composition correspond closely with reported values for those properties of factor B. A radioimmunoassay was used to estimate the serum concentration of DBP-2 at 266 +/- 83 microgram/ml, which also corresponds with the level of factor B normally present in the serum. DBP-2 functions as factor B in the activation of factor B-depleted serum. Limited proteolytic treatment of DBP-2 produced a fragment pattern resembling that of factor B both in the m.w. of the fragments and their electrophoretic mobilities. By means of DNA affinity chromatography of the fragments produced by trypsinization, the DNA-binding domain of DBP-2 was localized.

摘要

人血清中能够结合DNA的一种主要蛋白质已被证明是补体激活替代途径的B因子。这种蛋白质被命名为DNA结合蛋白-2(DBP-2),它可被针对B因子及其活化形式Bb片段的抗血清识别。其分子量、电荷微不均一性和氨基酸组成与报道的B因子的这些特性值密切相符。采用放射免疫分析法估计DBP-2的血清浓度为266±83微克/毫升,这也与血清中正常存在的B因子水平相符。DBP-2在激活B因子缺陷血清中发挥B因子的作用。对DBP-2进行有限的蛋白水解处理,产生的片段模式在片段分子量及其电泳迁移率方面都类似于B因子。通过对胰蛋白酶消化产生的片段进行DNA亲和层析,确定了DBP-2的DNA结合结构域。

相似文献

1
Identification of a major serum DNA-binding protein as factor B of the alternative complement pathway.鉴定一种主要的血清DNA结合蛋白为替代补体途径的B因子。
J Immunol. 1980 Jun;124(6):2800-6.
2
Activation of the alternative pathway of complement by antiserum to factor B.用抗B因子抗血清激活补体替代途径。
J Lab Clin Med. 1979 Mar;93(3):493-8.
3
Heterogeneous nature of human complement factor B: an electrophoretic approach for the analysis of its oligosaccharide chain structure and its physiological breakdown products.人补体因子B的异质性:一种用于分析其寡糖链结构及其生理降解产物的电泳方法。
Electrophoresis. 1989 Jul;10(7):501-12. doi: 10.1002/elps.1150100710.
4
Activated factor B (Bb) of the alternative pathway of complement activation cleaves and activates plasminogen.补体激活替代途径的活化因子B(Bb)可裂解并激活纤溶酶原。
J Immunol. 1981 Sep;127(3):877-80.
5
[Quantitation of intact form of complement protein B and its fragment Ba in human serum by radioimmunoassay].[放射免疫分析法测定人血清中补体蛋白B的完整形式及其片段Ba]
Ryumachi. 1990 Apr;30(2):103-8.
6
Metal-dependent conformational changes in a recombinant vWF-A domain from human factor B: a solution study by circular dichroism, fourier transform infrared and (1)H NMR spectroscopy.人补体因子B重组vWF-A结构域中金属依赖性构象变化:圆二色光谱、傅里叶变换红外光谱和¹H核磁共振光谱的溶液研究
J Mol Biol. 2000 Apr 21;298(1):135-47. doi: 10.1006/jmbi.2000.3632.
7
The alternative complement pathway in chickens. Purification of factor B and production of a monospecific antibody against it.鸡的替代补体途径。B因子的纯化及其单特异性抗体的制备。
Acta Pathol Microbiol Immunol Scand C. 1986 Dec;94(6):253-9.
8
Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library.从噬菌体展示随机肽库中分离出的一种C3结合肽对人补体的抑制作用。
J Immunol. 1996 Jul 15;157(2):884-91.
9
CRIT peptide interacts with factor B and interferes with alternative pathway activation.CRIT肽与B因子相互作用并干扰替代途径的激活。
Biochem Biophys Res Commun. 2006 May 26;344(1):308-14. doi: 10.1016/j.bbrc.2006.03.101. Epub 2006 Mar 27.
10
Human complement factor B: functional properties of a recombinant zymogen of the alternative activation pathway convertase.人补体因子B:替代激活途径转化酶重组酶原的功能特性
Immunobiology. 1993 Jul;188(3):221-32. doi: 10.1016/S0171-2985(11)80231-7.

引用本文的文献

1
Extracellular DNA Traps: Origin, Function and Implications for Anti-Cancer Therapies.细胞外DNA陷阱:起源、功能及对癌症治疗的意义
Front Oncol. 2022 Apr 27;12:869706. doi: 10.3389/fonc.2022.869706. eCollection 2022.
2
Amino acid sequence of the UP1 calf thymus helix-destabilizing protein and its homology to an analogous protein from mouse myeloma.小牛胸腺解螺旋蛋白UP1的氨基酸序列及其与小鼠骨髓瘤中类似蛋白的同源性。
Proc Natl Acad Sci U S A. 1985 Sep;82(17):5666-70. doi: 10.1073/pnas.82.17.5666.
3
Identification of a nucleic acid helix-destabilizing protein from rat liver as lactate dehydrogenase-5.
从大鼠肝脏中鉴定出一种核酸螺旋解旋蛋白为乳酸脱氢酶-5。
Proc Natl Acad Sci U S A. 1985 Aug;82(16):5260-4. doi: 10.1073/pnas.82.16.5260.